Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis-Reference-Cited by-同舟云学术

Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis

Published:2018-08 Issue: Volume:321 Page:41-48
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Fagone Paolo,Mazzon Emanuela,Chikovani Tinatin,Saraceno Andrea,Mammana Santa,Colletti Giuseppe,Mangano Katia,Bramanti Placido,Nicoletti Ferdinando

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference49 articles.

1. Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets;Adachi;Intern. Med.,1992

2. Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia;Aslam;Blood,2012

3. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity;Barcellini;Lupus,1996

4. Low-dose 5-aza-2′-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells;Chan;Mol. Med.,2014

5. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome;Chi;J. Neuroimmunol.,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Mechanisms Underlying Neuroimmune Diseases;Neuroimmune Diseases;2024

2. Role of regulatory T cells in pathogenesis and therapeutics of Guillain–Barré syndrome and experimental autoimmune neuritis;Regulatory T Cells and Autoimmune Diseases;2024

3. Progress in Guillain–Barré syndrome immunotherapy—A narrative review of new strategies in recent years;Human Vaccines & Immunotherapeutics;2023-06-06

4. Celastrol attenuates Guillain-Barré syndrome by inhibiting TLR4/NF-κB/STAT3 pathway-mediated Th1/Th17 cell differentiation;General physiology and biophysics;2023

5. Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism;JCI Insight;2022-11-22